Rectification order of 3 September 2021.#Sun Pharmaceutical Industries Ltd, anciennement Ranbaxy Laboratories Ltd and Ranbaxy (UK) Ltd v European Commission.#Rectification of judgment.#Case C-586/16 P.

ORDER OF THE COURT (Fourth Chamber)

3 September 2021 (*)

(Rectification of judgment)

In Case C‑586/16 P‑REC,

APPEAL under Article 56 of the Statute of the Court of Justice of the European Union, brought on 17 November 2016,

Sun Pharmaceutical Industries Ltd, formerly Ranbaxy Laboratories Ltd, established in Vadodara (India),

Ranbaxy (UK) Ltd, established in Hayes (United Kingdom),

represented by R. Vidal, Solicitor, and B. Kennelly QC and by L. Penny, Solicitor,

applicants,

the other parties to the proceedings being:

European Commission, represented by F. Castilla Contreras, T. Vecchi, B. Mongin and C. Vollrath, acting as Agents, and by D. Bailey, Barrister,

defendant at first instance,

supported by:

United Kingdom of Great Britain and Northern Ireland, represented initially by D. Guðmundsdóttir, Z. Lavery and D. Robertson, acting as Agents, and by J. Holmes QC, and subsequently by D. Guðmundsdóttir, acting as Agent, and by J. Holmes QC,

intervener in the appeal,

THE COURT (Fourth Chamber),

composed of M. Vilaras, President of the Chamber, D. Šváby (Rapporteur), S. Rodin, K. Jürimäe and P.G. Xuereb, Judges,

Advocate General: J. Kokott,

Registrar: A. Calot Escobar,

after hearing the Advocate General,

makes the following

Order

1        On 25 March 2021, the Court (Fourth Chamber) delivered the judgment in Sun Pharmaceutical Industries and Ranbaxy (UK) v Commission (C‑586/16 P, not published, EU:C:2021:241).

2        The introductory part of that judgment contains errors which it is appropriate for the Court to rectify at the request of the European Commission, pursuant to Article 154(1) of the Rules of Procedure of the Court of Justice, which applies to the procedure on appeal pursuant to Article 190(1) of those rules.

On those grounds, the Court (Fourth Chamber) hereby orders:

1.      In the introductory part of the judgment of 25 March 2021, Sun Pharmaceutical Industries and Ranbaxy (UK) v Commission (C‑586/16 P, not published, EU:C:2021:241) the reference to the European Commission’s representatives shall be rectified as follows:

‘European Commission, represented by F. Castilla Contreras, T. Vecchi, B. Mongin and C. Vollrath, acting as Agents, and by D. Bailey, Barrister,’

2.      The original of this order shall be annexed to the original of the rectified judgment. A note of this order shall be made in the margin of the original of the rectified judgment.

Luxembourg, 3 September 2021.

---

*      Language of the case: English.